Flyte Aviation, One of the Nation’s Largest Vision Jet Operators, Congratulates Cirrus Aircraft on Ten Years of Innovation
Flyte Aviation's Catheter Precision Publishes Comparative Study Evaluating Its LockeT Suture Retention Device Against A Traditional Internal Vascular Closure Device Following Large Bore Venous Access
Catheter Precision to Change its Name and Ticker Symbol to Flyte Aviation and “VJET” and Effect 1-for-10 Reverse Stock Split, Monday, October 5, at Market Open
Catheter Precision Board Approves Rebranding To Flyte Aviation And 1-For-10 Reverse Stock Split, Effective October 5, 2026
Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil
Catheter Precision Announces Significant Commercial Growth Across Its LockeT And VIVO Product Lines Via New U.S. Distribution Channels, Premier Hospital Adoption And International Expansion
Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates
Catheter Precision's Flyte Subsidiary Surpasses Over 10K Consumer Accounts Registered On Flyte WebApp
Flyte Partners with The Nucleus Network for Inaugural Flagship Founder & Investor Event
Flyte Achieves Record Revenues in July
Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons
FLYTE Partners with 319 Golf Society and Named Exclusive Private Aviation Partner
Catheter Precision's Fly Flyte Subsidiary Collaborates With Blade Urban Air Mobility To Expand Client Reach, Raise Booking Opportunities, Enhance Aircraft Utilization
VTAK Announces Preliminary Second Quarter Record Revenue in Excess of $1 million
Catheter Precision Reports Preliminary Q2 Revenue Of $1.037M
Catheter Precision (VTAK) Stock Surges Over 19% After Hours: Why is it Moving?
Catheter Precision (VTAK) Stock Soars Nearly 27% After-Hours: Here's Why it is Trending
Catheter Precision, Inc. Announces Issuance of Two Key Patents
Flyte Announces Successful Launch of New Direct-to-Consumer Booking Platform
What's Going On With Catheter Precision Stock On Friday?
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.